The transaction was disclosed in a filing with the U.S. Securities and Exchanges Commission.
The shares were sold at an average of $40.73 each for a total of $122,190.
Mr. Holden now owns 291,198 company shares, valued an estimated $11,860,495.
More Articles on Transactions and Valuation:
7 Recent Eye Surgery Center Plans, Expansions & Achievements
5 Recent Ambulatory Surgery Center Acquisitions & Partnerships
ASC & Hospital Partnerships: Weighing the Pros & Cons
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
